Posard Matthew L.
SEC insider (Form 3/4/5 filer). CIK 0001543792. Director at HALOZYME THERAPEUTICS, INC. (HALO) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SAN DIEGO, CA.
Companies Posard Matthew L. has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Director
- Nautilus Biotechnology, Inc. (NAUT): Director
Posard Matthew L.
CIK: 0001543792
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Oct 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect1.1K shares at avg. $109.57$121K - Oct 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect100 shares at avg. $110.04$11K - Oct 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect730 shares at avg. $107.17$78K - Oct 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect3.3K shares at avg. $108.45$358K - Sep 16, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect8.9K shares at avg. $108.04$961K - Sep 16, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect4K shares at avg. $108.99$436K - Sep 16, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect3.1K shares at avg. $106.13$329K - Sep 16, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect3K shares at avg. $106.83$320K - Jun 18, 2026NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
45K shares- - May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect3.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  HALO HALOZYME THERAPEUTICS, INC. | Sale | 1,100 | $109.57 | $120,526 | Direct |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 100 | $110.04 | $11,004 | Direct |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 730 | $107.17 | $78,233 | Direct |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 3,300 | $108.45 | $357,898 | Direct |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 8,896 | $108.04 | $961,124 | Direct |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 4,000 | $108.99 | $435,964 | Direct |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 3,100 | $106.13 | $329,009 | Direct |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 3,000 | $106.83 | $320,484 | Direct |
| Jun 18, 2026 |  NAUT Nautilus Biotechnology, Inc. | Award Stock Option (Right to Buy) | 45,000 | - | - | Direct |
| May 5, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award | 3,796 | - | $0 | Direct |
1-10 of 12 transactions